Tract – based spatial statistics in patients with small cell lung cancer (original) (raw)
Transformation of Physical DVHs to Radiobiologically Equivalent Ones in Hypofractionated Radiotherapy Analyzing Dosimetric and Clinical Parameters: A Practical Approach for Routine Clinical Practice in Radiation Oncology
George Matsopoulos
Computational and Mathematical Methods in Medicine, 2013
View PDFchevron_right
Critical dose and toxicity index of organs at risk in radiotherapy: Analyzing the calculated effects of modified dose fractionation in non–small cell lung cancer
Giovanni Storto, Alba Fiorentino
Medical Dosimetry, 2014
View PDFchevron_right
Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging-Based Internal Dosimetry
Eric Frey
Journal of Nuclear Medicine, 2007
View PDFchevron_right
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer
Su-min Zhou
International Journal of Radiation Oncology*Biology*Physics, 2001
View PDFchevron_right
Inclusion of functional information from perfusion SPECT improves predictive value of dose–volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study
Jesper Kallehauge
Radiotherapy and Oncology, 2015
View PDFchevron_right
Organ at risk dose measurements following radiotherapy treatment for breast cancer patients
Ibrahim Duhaini
Health and Technology, 2018
View PDFchevron_right
Three-Dimensional Radiobiological Dosimetry ( 3 DRD ) : Application of Radiobiological Modeling to Patient-Specific , 3-D Imaging-based Internal Dosimetry
Andrew Prideaux
2007
View PDFchevron_right
The choice of statistical methods for comparisons of dosimetric data in radiotherapy
Abdulhamid Chaikh
Radiation Oncology, 2014
View PDFchevron_right
A statistical quantification of radiobiological metrics in Intensity Modulated Radiation Therapy evaluation
P.Sasikala Asst. Prof, ECE
The Gulf journal of oncology, 2015
View PDFchevron_right
The relationship between dosimetric factors, side effects, and survival in patients with non–small cell lung cancer treated with definitive radiotherapy
Deniz Sigirli
Medical Dosimetry, 2017
View PDFchevron_right
The importance of patient characteristics for the prediction of radiation-induced lung toxicity
Shipeng Yu
Radiotherapy and Oncology, 2009
View PDFchevron_right
Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non–small-cell lung cancer
Wolfgang Schlegel, Ina Kyas, Juergen Debus
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
Dosimetric Evaluation of Heterogeneity Corrections for RTOG 0236: Stereotactic Body Radiotherapy of Inoperable Stage I-II Non–Small-Cell Lung Cancer
Jeff Michalski
International Journal of Radiation Oncology*Biology*Physics, 2009
View PDFchevron_right
Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)
Mike Partridge
Physics in Medicine and Biology, 2009
View PDFchevron_right
Methodological issues in radiation dose–volume outcome analyses: Summary of a joint AAPM/NIH workshop
Mark Langer
Medical Physics, 2002
View PDFchevron_right
Dosimetric Analysis of Three Different Radiotherapy Techniques in Patients with Breast Cancer and Their Impact on Organs at Risk (OAR)
vikas jagtap
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 2018
View PDFchevron_right
Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
Suneetha Devpura
Clinical and Translational Radiation Oncology
View PDFchevron_right
Effect of Normal Lung Definition on Lung Dosimetry and Lung Toxicity Prediction in Radiation Therapy Treatment Planning
yue cao
International Journal of Radiation Oncology*Biology*Physics, 2013
View PDFchevron_right
The relationship between local dose and loss of function for irradiated lung
Ritsuko Komaki
International Journal of Radiation Oncology*Biology*Physics, 2003
View PDFchevron_right
Regional differences in lung radiosensitivity after radiotherapy for non–small-cell lung cancer
José Belderbos
International Journal of Radiation Oncology*Biology*Physics, 2004
View PDFchevron_right
Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer
Kellie Knight
Physics and Imaging in Radiation Oncology
View PDFchevron_right
Radiobiological Evaluation of the Radiation Dose as Used in High-precision Radiotherapy: Effect of Prolonged Delivery Time and Applicability of the Linear-quadratic Model
Yuta Shibamoto
Journal of Radiation Research, 2012
View PDFchevron_right
Dosimetric differences between local failure and local controlled non-small cell lung cancer patients treated with stereotactic body radiotherapy: A matched-pair study
Chandana Reddy
Journal of medical imaging and radiation oncology, 2018
View PDFchevron_right
Localized Volume Effects for Late Rectal and Anal Toxicity After Radiotherapy for Prostate Cancer
Stefaan Peeters
International Journal of Radiation Oncology*Biology*Physics, 2005
View PDFchevron_right
Measuring dose in lung identifies peripheral tumour dose inaccuracy in SBRT audit
Moshi Geso
Physica Medica
View PDFchevron_right
Systematic review of dose–volume parameters in the prediction of esophagitis in thoracic radiotherapy
Brian Yaremko
Radiotherapy and Oncology, 2009
View PDFchevron_right
The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
Carlo Chiesa, Glenn Flux
European Journal of Nuclear Medicine and Molecular Imaging, 2014
View PDFchevron_right
Tissue Heterogeneity in IMRT Dose Calculation for Lung Cancer
lidia strigari
Medical Dosimetry, 2011
View PDFchevron_right
Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung cancer treatment: do we need to measure radiotherapy outcomes to tune the radiobiological parameters of a normal tissue complication probability model?
Pierre-Yves Bondiau
Translational lung cancer research, 2016
View PDFchevron_right